FDA Predictor
Upcoming FDA decisions on real drugs. Approval estimates appear only from a released model, always with its version, range and reasons.
Model status: not released.
The FDA approval model is being tested on past FDA decisions. Estimates appear only after it passes all nine release checks and a second admin approves it, so P(Approve), the 95% CI and Confidence read “Not released” for every drug. How estimates work
No validated model has passed the release gates.
Filter drugs
FDA Approval Predictions
| Drug | Horizon | CT-VCA | P(Approve) | 95% CI | PDUFA | Confidence |
|---|---|---|---|---|---|---|
| Cemdisiran | Filed | 29 days left in the period | ||||
| BXCL501 | Phase 3 | 13 days to go | ||||
| Ivonescimab | Phase 3 | 13 days to go | ||||
| Povetacicept | Filed | 29 days to go |
Dates come from company and FDA disclosures and can change. Confidence levels arrive with a released model (P-11). Nothing here is investment advice.
Your plan shows the next 30 days. Pro shows every date.